Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitus

Ítems similars

• Effects of the small molecule SIRT1 activator, SRT2104 on arterial stiffness in otherwise healthy cigarette smokers and subjects with type 2 diabetes mellitus
  per: Venkatasubramanian, Sowmya, et al.
  Publicat: (2016)
• Cardiovascular Effects of a Novel SIRT1 Activator, SRT2104, in Otherwise Healthy Cigarette Smokers
  per: Venkatasubramanian, Sowmya, et al.
  Publicat: (2013)
• Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man
  per: Hoffmann, Ethan, et al.
  Publicat: (2013)
• Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative Colitis
  per: Sands, Bruce E., et al.
  Publicat: (2015)
• A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes
  per: Baksi, Arun, et al.
  Publicat: (2014)